DIRS.INFO The most relevant business & tech news

☆ Here are Friday's biggest analyst calls: Nvidia, Tesla, Apple, Rivian, Micron, Microsoft, Eli Lilly, Amazon & more
▼ + stars: | 2024-03-15 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Citi upgrades Thor Industries to buy from neutral Citi said it see a "favorable event path" for the RV company. " Citi initiates Pure Storage as buy Citi said in its initiation of Pure Storage that the data storage company is an AI beneficiary. Citi reiterates Apple as buy Citi said it's standing by its buy rating on shares of Apple. Bank of America reiterates Amazon as buy Bank of America said it's bullish heading into Amazon's Spring Sales event next week. Citi reiterates Micron as buy Citi raised its price target on the stock to $150 per share from $95 and says it's bullish heading into earnings next week. "

Persons: Piper Sandler, Piper, Morgan Stanley, RSG, Cummins, Baird, Nvidia, JPMorgan, Tesla, Telsey, Todd Vasos, it's, Stellantis, Five9, PBF, DINO, Truist, Eli Lilly, LLYs, Dave Ricks, Patrik Jonsson Organizations: EV, Bank of America, Adobe, Citi, Thor Industries, Morgan Stanley downgrades Republic Services, UBS, Cummins, CMI, Microsoft, Nvidia, JPMorgan, Guggenheim, Apple, Worldwide, " Bank of America, Micron, Catalyst Watch, RBC, UFC, WWE, Inc, Valero Energy, Sinclair, of America, Entertainment, Golden Entertainment, Diabetes, Obesity Locations: Snowflake, F4Q24, China, Nevada

☆ Call of the Day: Eli Lilly
▼ + stars: | 2024-03-15 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCall of the Day: Eli LillyJP Morgan is hiking Eli Lilly's price target to $850. The Investment Committee debate it.

Persons: Eli Lilly JP Morgan, Eli

☆ Why weight-loss drugs like Ozempic are a game-changer for the global economy
▼ + stars: | 2024-03-15 | by ( Phil Rosen | ) www.businessinsider.com time to read: +5 min

Capital Economics said weight-loss drugs could be game-changers for the world economy. Eventually, AI could supercharge the healthcare sector, so weight-loss drugs could be just the beginning. Capital Economics noted that share prices fell in 2023 for many fast-food companies as weight-loss drugs gained popularity, though some of those losses have since been pared. Weight-loss drugs and AIGLP-1 drugs' emergence, meanwhile, has happened alongside the explosion of artificial intelligence technology and hype. If so, the economic gains heralded by weight-loss drugs might be just the beginning."

Persons: —, Goldman Sachs, Eli Lilly Organizations: Service, Capital Economics, Nordisk, Organization, Economic Cooperation, Development Locations: Mexico, America, Denmark, Korea

☆ WeightWatchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
▼ + stars: | 2024-03-14 | by ( Eric Rosenbaum | ) www.cnbc.com time to read: +6 min

But since then WW shares have suffered heavy selling, dropping to a new 52-week low on Thursday. The stock, due to its debt load and short interest, as well as the general anxiety about the impact of the new weight loss drugs, is subject to heightened volatility. In the memo, Sistani told employees she wanted "to take a moment to address some of the breathless media coverage." WW shares closed at $1.87 on Thursday. It noted that WW was among companies from the weight loss industry involved in the TV event.

Persons: Oprah Winfrey, Sistani, Eli Lilly, Sima Sistani, Guggenheim, Oprah, Winfrey Organizations: CNBC, Nordisk, Guggenheim Partners, Guggenheim, WeightWatchers Clinic, FDA, WeightWatchers, National Museum of, ABC

☆ 'Dollars up, donors down': More charity money is coming from the ultra-wealthy
▼ + stars: | 2024-03-14 | by ( Robert Frank | ) www.cnbc.com time to read: +5 min

While donations to charity have been rising, the pool of donors is shrinking, as philanthropy becomes hyper-concentrated among a small group of ultra-wealthy mega-donors, according to a new study. While women make up11% of the ultra-high-net-worth population, they account for 22% of the larger givers, according to the study. Today’s ultra-wealthy donors also prefer to give through private foundations and donor-advised funds — which give them more control — rather than simply writing checks to the Red Cross or United Way. The top charitable cause for ultra-wealthy donors was education (at 54%), according to Altrata. "There is some evidence that the ultra-high-net-worth population has different skews from the broader population," Pasic said.

Persons: Melinda Gates, Robert Frank, Mark Suzman, Amir Pasic, Indiana University Lilly, ”, “, Altrata, Pasic Organizations: Gates Foundation, Indiana University, Indiana University Lilly Family School of Philanthropy, Cross, Federal Reserve Locations: Khayelitsha, Cape Town , South Africa, Altrata, North

☆ FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
▼ + stars: | 2024-03-14 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide. Novo Nordisk and Eli Lilly are testing their respective blockbuster weight loss injections as treatments for the same kind of liver disease, called nonalcoholic steatohepatitis, or NASH. Madrigal's drug, which will be marketed as Rezdiffra, is specifically approved to treat patients with NASH who also have moderate-to-advanced liver scarring. NASH is a serious form of liver disease characterized by excess fat buildup and inflammation in the liver and can lead to liver scarring, also known as fibrosis, along with liver failure and liver cancer. Roughly 6 million to 8 million people in the U.S. have NASH with moderate-to-advanced liver scarring, according to an estimate cited by the FDA.

Persons: Madrigal, Eli Lilly, NASH, Nikolay Nikolov, Rezdiffra Organizations: Madrigal Pharmaceuticals, Drug Administration, Pharmaceuticals, Novo Nordisk, FDA, Immunology Locations: U.S

☆ Stocks making the biggest moves premarket: Dollar Tree, Petco, Tesla and more
▼ + stars: | 2024-03-13 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Check out the companies making headlines before the bell: Dollar Tree — Shares dropped 7% after the discount retailer posted disappointing quarterly results and announced the closure of several stores. Dollar Tree also said it plans to close nearly 1,000 stores. Texas Roadhouse — Shares gained 1.5% after Baird upgraded the restaurant chain to outperform, citing the strength of its relatively strong traffic. Eli Lilly , Amazon — Eli Lilly on Wednesday said it's partnering with Amazon Pharmacy to help deliver certain prescription drugs, including weight loss treatment Zepbound . Shares of Eli Lilly gained nearly 1%, while Amazon shares were slightly lower.

Persons: LSEG, Wells, Goldman Sachs, Bitdeer, Baird, Eli Lilly, — CNBC's Michelle Fox, Fred Imbert, Tanaya Macheel Organizations: Petco, Wellness, Royal, Marathon, Iris Energy, GE Healthcare Technologies, GE HealthCare Technologies, Texas, Amazon Pharmacy Locations: Royal Caribbean

☆ Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
▼ + stars: | 2024-03-13 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients' homes through the drugmaker's new direct-to-consumer program. The website, LillyDirect, connects people with an independent telehealth company that can prescribe certain drugs if they are eligible. LillyDirect plans to expand the medicines it offers and the companies it partners with in the future, Eli Lilly said. Amazon Pharmacy offers free two-day deliveries to patients with an Amazon Prime membership, which will also apply if they use LillyDirect. But he told CNBC that Eli Lilly expects Amazon Pharmacy and Truepill to have similar processing and shipping times.

Persons: Eli Lilly, Eli Lilly's, Frank Cunningham, Cunningham, Truepill, John Love, We're, Lilly Organizations: Amazon Pharmacy, Amazon, CNBC Locations: U.S

☆ Experts hesitate on weight loss ETFs amid the obesity drug boom
▼ + stars: | 2024-03-13 | by ( Anna Gleason | ) www.cnbc.com time to read: +1 min

There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. With just two players currently at the forefront of the U.S. obesity drug market, ProShares' Simeon Hyman questions the relevance of weight loss ETFs for investors looking to buy into the industry. "If the benefits are going to incumbents, then maybe there isn't a theme per se that needs to be exploited." Strategas' Sohn also suggested that ETFs based on themes, rather than sectors or indices, might be falling out of favor with investors. So far in 2024, Novo Nordisk has gained 29% and Eli Lilly is up 30%, as of Wednesday's close.

Persons: Todd Sohn, Eli Lilly, Lilly, CNBC's, ProShares, Simeon Hyman, Sohn Organizations: Roundhill, Novo Nordisk Locations: U.S, Novo

☆ 10 things to watch in the stock market, including Eli Lilly, Amazon, Meta and Ford
▼ + stars: | 2024-03-13 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

BofA also raises red-hot server maker Super Micro Computer price target to $1,280 from $1,040. The Club stock took off in mid-February after the previous secondary. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Eli Lilly, BofA, ByteDance, Morgan Stanley's Adam Jonas, Jonas, Morgan Stanley, Tesla, Wells, Jim Cramer's, Jim Cramer, Jim Organizations: Investors, Bank of America, Electric, GE Healthcare, Club, Auto, General Motors, Ford, Citigroup, Constellation Brands, Citi, Nielsen, Corona, Modelo, Jim Cramer's Charitable, CNBC Locations: Pacifico, Cleveland

☆ 3 hot stocks rally after sharp back-to-back losses. Plus, 1 stock to consider buying
▼ + stars: | 2024-03-12 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, We're, Jamie Dimon, Jim, Dimon, Eli Lilly, it's, Jim Cramer's Organizations: CNBC, Nasdaq, JPMorgan, Oracle, Nvidia, Costco, Broadcom

☆ Musk’s haphazard philanthropy is under scrutiny
▼ + stars: | 2024-03-12 | by ( Allison Morrow | ) edition.cnn.com time to read: +2 min

As CEO of Tesla, “I’ve done more for the environment than any single human on Earth,” he told the New York Times last year. But American tax law dangles some significant incentives for them to do so. Musk likely managed to shave a couple billion off his $11 billion tax bill in 2021, thanks to the $5.7 billion he donated to the Musk Foundation, according to the Times. In Musk’s case, according to the Times, that meant giving millions of dollars to Cameron County, Texas. “The way I see Elon Musk is that he’s really pushing the limits of the alternative approaches to philanthropy,” Pasic said.

Persons: CNN Business ’, New York CNN — Elon Musk, Tesla, ”, MacKenzie Scott, Jeff Bezos, “, ’, ’ ” Musk, Musk, ” Amir Pasic, Indiana University Lilly, Elon, ” Pasic Organizations: CNN Business, New York CNN, New York Times, Musk, Times, Indiana University, Indiana University Lilly Family School of Philanthropy, SpaceX Locations: New York, Cameron County , Texas

☆ The great YouTube exodus is coming — leaving AI junk and MrBeast to reign supreme
▼ + stars: | 2024-03-12 | by ( Lindsay Dodgson | ) www.businessinsider.com time to read: +12 min

Read previewWhen MatPat announced he would leave behind his renowned YouTube channel The Game Theorists this year, he also had a prediction: 2024 will be the year we see a mass exodus from the platform. Speaking with the Guardian, he said he'd seen many of his peers reducing how much time they were dedicating to YouTube. AdvertisementJenna Marbles said goodbye to her YouTube channel back in 2020 after criticism over her old content. Hannah Witton / YouTubeScaling up in an AI worldWitton said she's always been aware of the "growth trap" creators can fall into. "I've seen cheap five-second videos of just an AI voice reading a summary of a movie," Tran said.

Persons: —, MatPat, YouTubers, Jenna Marbles, Tyler Oakley, Tanya Burr —, Zoe Sugg, Lilly Singh, Dave Kotinsky, Matthew Patrick, Patrick, Stephanie, Tom Scott, he'd, Zoe Glatt, Glatt, YouTube's, Ollie, He's, Hannah Witton, it's, you've, Witton, she's, we've, Christine Tran, Tran, Emma Chamberlain, Jacopo Raule, That's, It's Organizations: Service, YouTube, Business, Media, Guardian, University of Toronto Locations: Suez, Witton

☆ Here are Monday's biggest analyst calls: Nvidia, Tesla, Netflix, Adobe, Amazon, Eli Lilly, Procter & Gamble & more
▼ + stars: | 2024-03-11 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Here are Monday's biggest calls on Wall Street: Morgan Stanley reiterates Nvidia as overweight Morgan Stanley said the stock is a top idea after coming out of the company's recent TMT conference. " Morgan Stanley downgrades Hyatt to equal weight from overweight Morgan Stanley said in its downgrade of the stock that risk/reward is more balanced. Morgan Stanley reiterates Eli Lilly as overweight Morgan Stanley said the next catalyst for Eli Lilly is the results from the company's sleep apnea trial. Morgan Stanley initiates Phinia as overweight Morgan Stanley initiated the auto components and supplier company and says it's a "key beneficiary of the EV reset." Morgan Stanley reiterates Meta as overweight Morgan Stanley said it's standing by shares of Meta.

Persons: Morgan Stanley, Oppenheimer, underperform Jefferies, Jefferies, Tesla, Evercore, Tesla's, Tesla's Austin Gigafactory, Wolfe, XEL, Morgan Stanley downgrades Hyatt, JPMorgan, Stifel, Eli Lilly, Truist, Guggenheim, it's, PDD, Locker, Meta, Goldman Sachs, Goldman Organizations: Netflix, Jefferies, Wyndham, Underperform, Wyndham Hotels, Adobe, & Highland, JPMorgan, Energy, Hyatt, Petrobras, Procter, Gamble, Guggenheim, Nike, ICE, UBS, Apple, Meta, & & / Locations: Tesla's, Texas, bullish, China, Kazakhstan, America

☆ 3 momentum stocks are on back-to-back declines. Jim Cramer looks at whether to buy the dips
▼ + stars: | 2024-03-11 | by ( Jeff Marks | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. "You know I hate parabolic moves," Jim Cramer said Monday. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Eli Lilly, Jim, Truist, Jim Cramer's Organizations: CNBC, Dow, Nasdaq, Broadcom, Costco, Procter & Gamble, Procter

☆ Top 10 things to watch in the market Monday, including 5 portfolio stocks
▼ + stars: | 2024-03-11 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

The analysts say in 2024 look for consumer packaged goods companies with volume growth, which has been our view, too. The analysts say "stay the course" and have trust that leadership will innovate. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Morgan Stanley, Eli Lilly, Oppenheimer, Jefferies, Jim Cramer's, Jim Cramer, Jim Organizations: Nasdaq, Procter & Gamble, Nike, Guggenheim, Netflix, UBS, Apple, Troubled, Adobe, Jim Cramer's Charitable, CNBC Locations: Truist, U.S

☆ Stocks making the biggest moves midday: Nvidia, Coinbase, Oracle, Bally's and more
▼ + stars: | 2024-03-11 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Oracle — Shares added 1.6% ahead of the software giant's fiscal third-quarter earnings report due after the bell. Analysts polled by FactSet are expecting earnings per share of $1.38 and revenue of $13.29 billion. New York Community Bancorp — The regional bank stock dropped 4.8%, extending losses after Friday's more than 6% drop. Moderna — The stock jumped more than 8% in midday trading, putting it on track for its biggest one-day gain since December. Duolingo — Shares rose 3.6% after JPMorgan initiated coverage of the online learning platform with an overweight rating, forecasting "premium" revenue growth that could substantially drive up Duolingo's valuation.

Persons: FactSet, Lam, Coinbase, Microstrategy, Jefferies, Eli Lilly, — CNBC's Michelle Fox, Alex Harring, Yun Li, Tanaya Macheel, Pia Singh Organizations: Oracle, Nvidia, Semiconductor, Lam Research, New York Community Bancorp, Moderna, P Biotech, Xcel Energy, Barclays, JPMorgan, PDD Holdings

☆ Time to sell Nvidia? How to trade stocks that have 'gone parabolic'
▼ + stars: | 2024-03-11 | by ( Katie Stockton | ) www.cnbc.com time to read: +7 min

When stocks are in steep uptrends, it can difficult be difficult to determine when a meaningful corrective move is going to take place. Two examples of steep uptrends are Meta (Meta) and Nvidia (NVDA) , both of which are pictured below. Fairlead Strategies Disclaimer: This communication has been prepared by Fairlead Strategies LLC ("Fairlead Strategies") for informational purposes only. Securities, investment products, other financial products or strategies discussed herein may not be suitable for all investors. The recipient of this information must make its own independent decisions regarding any securities, investment products or other financial products mentioned herein.

Persons: Berkshire Hathaway, Eli Lilly, NVDA, Katie Stockton Organizations: Microsoft, Nvidia, Broadcom, JPMorgan Chase, Fairlead, CNBC Pro, Securities Locations: Meta, Berkshire

☆ Exclusive: Ex-Truepill CEO just scored $6 million to help health plans and pharma companies ditch middlemen and work closely with patients
▼ + stars: | 2024-03-11 | by ( ) www.businessinsider.com time to read: +5 min

He's launched a new company, Foundation Health, to help them do that quickly and at a low cost. Foundation aims to make it easy for insurers to set up their own online pharmacies and pharma companies to sell drugs directly to consumers. "The main focus area for us is to help health plans disintermediate PBMs," Afridi said. Foundation Health wants to help customers ditch big PBMsFoundation's software enables a few different things. Finally, direct-to-consumer health companies can plug into Foundation's technology to power their services, instead of building their own pharmacies and hiring doctors.

Persons: Umar Afridi, disruptors, Afridi, He's, disintermediate, Garry Tan, Y, they've, pocketing, Eli Lilly's, Jack Altman Organizations: California, Cuban, Plus, Business, Foundation Health, Foundation, pharma, Alt, Liquid Ventures, Exceptional, Storm Ventures, PageOne Ventures, Federal Trade Commission Locations: drugmakers

☆ Nvidia's terrible Friday gives traders a preview of what a momentum unwind would look like
▼ + stars: | 2024-03-09 | by ( Michael Santoli | ) www.cnbc.com time to read: +8 min

The S & P 500 Volatility Index finished the week near 15 and is in a clear three- month uptrend from its mid-December low near 12, even as the S & P 500 has gained 10% since then. In fact, Friday the market minimized the headline damage to a mere two-thirds-percent dip in the S & P 500 through its signature rotational impulse. Some indicators — such as speculators remaining net short S & P 500 futures and brokerage strategists' muted index targets — imply the helpful wall of worry is not quite fully scaled. Since then, the S & P has delivered a 16.7% annualized total return, even after two bear markets and two other severe/prolonged corrections. And the S & P is only up 7% from its high 26 months ago, hardly in thin air.

Persons: what's, Eli Lilly, Martin Marietta, Nick Colas, Scott Chronert Organizations: Federal, Nvidia, Costco, pharma, Martin Marietta Materials, Vulcan, 3Fourteen Research, NYSE, Nasdaq, DataTrek, Citi

☆ Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
▼ + stars: | 2024-03-08 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly said Friday that the Food and Drug Administration has pushed back its approval decision deadline for the drugmaker's experimental Alzheimer's treatment donanemab in a surprise move. The agency plans to call a last-minute meeting of its outside advisors to further review the treatment's safety and efficacy in a late-stage trial, Eli Lilly said. It's another setback for Eli Lilly, which is racing to compete with Biogen and Eisai. In 2021, the FDA approved an earlier, ill-fated Alzheimer's drug called Aduhelm from Biogen and Eisai, despite a negative recommendation from the agency's advisory panel.

Persons: Eli Lilly, Eli Lilly's, Leqembi, Anne White Organizations: and Drug Administration, FDA Locations: Indianapolis , Indiana, Biogen

☆ Novo Nordisk's Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage
▼ + stars: | 2024-03-08 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. The approval also demonstrates that weight loss drugs have significant health benefits beyond shedding unwanted pounds and regulating blood sugar. The FDA said Wegovy patients should use Wegovy in addition to a reduced calorie diet and increased physical activity. Novo Nordisk expects to receive a similar Wegovy approval in the EU this year. The study tested Wegovy in roughly 17,500 people with obesity and heart disease but who did not have diabetes.

Persons: John Sharretts, Ozempic, Wegovy, Eli Lilly, Zepbound Organizations: Drug Administration, Novo Nordisk, Diabetes, FDA's Center, Drug, Research, FDA, Nordisk Locations: Oslo, Norway, Danish, U.S

☆ F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
▼ + stars: | 2024-03-08 | by ( Pam Belluck | ) www.nytimes.com time to read: +1 min

The Food and Drug Administration has decided to delay action on a closely watched Alzheimer’s drug, donanemab, which the agency was widely expected to approve this month. will instead require donanemab to undergo the scrutiny of a panel of independent experts, the drug’s maker, Eli Lilly and Company, said Friday. The decision is likely to surprise many Alzheimer’s experts, doctors and patients who had expected the medication would soon be on the market. The F.D.A.’s move was startling to the company, which had been planning for the agency to greenlight the drug during the first quarter of this year. “We were not expecting this,” Anne White, an executive vice president of Lilly and president of its neuroscience division, said in an interview.

Persons: Eli Lilly, “, Lilly, ” Anne White, ” Organizations: Drug Administration Locations: donanemab

☆ Committee stocks on the move: Costco, Eli Lilly, Netflix, Google and Gold
▼ + stars: | 2024-03-08 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCommittee stocks on the move: Costco, Eli Lilly, Netflix, Google and GoldThe Investment Committee discuss stocks in their portfolio.

Persons: Eli Lilly Organizations: Costco, Netflix, Google, The Investment

☆ Stocks making the biggest moves premarket: Carvana, Gap, Eli Lilly, UBS and more
▼ + stars: | 2024-03-08 | by ( Hakyung Kim | ) www.cnbc.com time to read: +4 min

The database software maker posted adjusted earnings of 86 cents per share on revenue of $458 million. Analysts had called for earnings of 47 cents per share and $433 million in revenue, according to LSEG. DocuSign reported fourth-quarter adjusted earnings of 76 cents per share on revenue of $712 million for the period. According to analysts surveyed by LSEG, Wall Street had expected earnings of 64 cents per share on $699 million in revenue. Eli Lilly — Shares slipped 1% premarket after the U.S. Food and Drug Administration delayed approving its Alzheimer's drug, donanemab.

Persons: MongoDB, DocuSign, Deutsche, Li, Morgan Stanley, LSEG, Eli Lilly —, —, Sarah Min, Michelle Fox, Jesse Pound Organizations: RBC, Li Auto, Deutsche Bank, Navy, UBS — U.S, UBS, Marvell Technology, Broadcom, Revenue, Textron —, Bank of America, Textron, New York Community Bancorp, Moody's, U.S . Food, Drug Administration, Costco —, LSEG Locations: Swiss, U.S

Search resuls for: "lilly"

25 mentions found